BRKR · XBRL financial data

Bruker financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BRKR's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	743	855*	722	801	864	980*	801	797	861	977*	823	839
Cost of revenue	360	424*	369	416	446	486*	410	440	481	528*	444	423
Gross profit	383	430*	353	385	419	493*	391	358	379	449*	380	416
Research and development	71	84*	82	92	98	104*	97	100	98	100*	101	94
Selling, general and administrative	178	211*	195	221	230	247*	225	231	243	247*	242	239
Total operating expenses	258	327*	288	337	351	421*	359	346	431	373*	370	481
Other operating income (expense)	(0)	(0)*	0	0	0	(0)*	1	0	3	(6)*	3	4
Operating income (loss)	125	104*	65	48	68	72*	32	12	(52)	76*	10	(65)
Interest income	2	2*	3	2	2	2*	3	3	4	5*	5	11
Interest expense	4	4*	5	16	12	16*	13	16	20	11*	12	18
Other income (expense)	—	year only	7	(24)	(13)	(8)*	(7)	(11)	(20)	(8)*	12	25
Income tax expense (benefit)	31	37*	20	16	15	41*	9	(3)	(14)	38*	3	14
Net income (loss)	88	206*	51	8	41	14*	17	8	(60)	26*	14	(52)
Earnings per share, basic USD per share	0.60	—	0.35	0.05	0.27	—	0.11	0.05	(0.41)	—	0.02	(0.41)
Earnings per share, diluted USD per share	0.60	—	0.35	0.05	0.27	—	0.11	0.05	(0.41)	—	0.02	(0.41)
Weighted average shares, basic millions of shares	0	0*	0	0	0	0*	0	152	152	—	152	152
Weighted average shares, diluted millions of shares	0	0*	0	0	0	0*	0	152	152	—	153	152

Fiscal quarters (BRKR's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	364	488	340	170	148	183	184	92	293	299	133	185
Accounts receivable	485	492	475	507	538	566	538	523	551	545	543	546
Inventory	916	968	1,061	1,176	1,220	1,068	1,117	1,218	1,197	1,095	1,122	1,120
Total current assets	2,029	2,164	2,140	2,153	2,191	2,053	2,112	2,163	2,351	2,213	2,104	2,225
Property and equipment, net	527	600	586	657	694	669	689	759	747	745	720	714
Right-of-use asset	—	92	105	136	148	146	—	—	—	166	—	—
Goodwill	561	583	752	1,444	1,475	1,507	1,533	1,649	1,550	1,548	1,573	1,430
Total assets	3,820	4,250	4,506	5,903	6,113	5,807	5,933	6,340	6,435	6,241	6,131	6,053
Accounts payable	182	203	199	220	228	234	245	243	184	216	269	200
Total current liabilities	1,072	1,202	1,183	1,305	1,322	1,281	1,345	1,347	1,268	1,279	1,355	1,205
Long-term debt	1,099	1,160	1,357	2,132	2,265	2,062	2,076	2,380	1,984	1,853	1,663	1,815
Lease liability, non-current	—	75	86	111	121	119	—	—	—	139	—	—
Total liabilities	—	2,837	3,056	4,078	4,270	3,992	—	—	—	3,731	—	—
Retained earnings	—	2,324	2,367	2,367	2,401	2,407	—	—	2,352	2,362	—	—
Total stockholders' equity	1,209	1,377	1,415	1,789	1,807	1,781	—	—	2,432	2,457	—	—
Total liabilities and equity	3,820	4,250	4,506	5,903	6,113	5,807	5,933	6,340	6,435	6,241	6,131	6,053
Common shares outstanding (cover page) millions of shares	138	138	145	151	152	152	152	152	151	152	152	152

Fiscal quarters (BRKR's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	88	206*	51	8	41	14*	17	8	(60)	26*	14	(52)
Stock-based compensation	6*	6*	5	7*	6*	7*	—	—	—	year only	—	—
Depreciation and amortization	27*	37*	35	45	51	53*	50	56	56	58*	58	58
Net cash from operating activities	44*	206*	22	1*	38*	190*	65	(128)*	(33)*	230*	71	(77)*
Purchases of property and equipment	27*	32*	21	25*	33*	37*	26	21*	21*	23*	24	29*
Net cash from investing activities	(155)*	(37)*	(304)	(1,325)*	(68)*	(61)*	(26)	(91)*	(24)*	(56)*	(40)	(25)*
Proceeds from issuing common stock	2*	5*	3	2*	(3)*	3*	0	5*	(1)*	4*	—	—
Share repurchases	80*	50*	0	0*	0*	0*	10	0*	0*	0*	0	—
Dividends paid	7*	7*	7	8*	8*	8*	8	8*	0*	8*	8	8*
Proceeds from long-term debt	0*	(1)*	0	4*	1*	969*	3	0*	0*	1*	0	0*
Repayments of long-term debt	—	year only	3	115*	10*	8*	8	15*	299*	145*	181	2*
Net cash from financing activities	(93)*	(60)*	152	1,156*	(3)*	(75)*	(51)	96*	258*	(168)*	(205)	149*
Net change in cash	(211)*	125*	(148)	(170)*	(22)*	35*	1	(92)*	201*	6*	(166)	52*

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Bruker	185	839	(77)*	152.4M	2.4 quarters	Q2 FY26 10-QJun 30, 2026
Sensata Technologies Holding	553	1,004	225*	145.6M	—	Q3 FY26 10-QSep 30, 2026
Mirion Technologies	409	278	59*	not reported	—	Q3 FY26 10-QSep 30, 2026
Cognex	303	291	69*	168.2M	—	Q2 FY26 10-QJul 5, 2026
Vontier	266	757	116*	135.2M	—	Q2 FY26 10-QJul 3, 2026
Bio-Rad Laboratories	517	651	99*	not reported	—	Q2 FY26 10-QJun 30, 2026
Ralliant	271	568	106*	110.6M	—	Q2 FY26 10-QJul 3, 2026
Itron	840	599	102*	43.9M	—	Q3 FY26 10-QSep 30, 2026
MKS	454	1,248	243*	67.6M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.